Prakt. lékáren. 2012; 8(1): 34-37

Symptomatic treatment of influenza

Jiří Slíva
Ústavy farmakologie 2. a 3. LF UK, Praha

Influenza is an acute viral disease, posing a particular risk for the elderly and for multimorbid patients; nevertheless, it does affect all

age groups. Despite available vaccination, however, epidemic or, less frequently, pandemic incidence of influenza is encountered due

to a constantly changing causative viral agent. A wider use of antiviral drugs (oseltamivir, zanamivir or amantadine) continues to have

limitations; therefore, symptomatic treatment still plays a dominant role.

Keywords: influenza, antitussives, antipyretics, vitamin C

Published: March 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Slíva J. Symptomatic treatment of influenza. Praktické lékárenství. 2012;8(1):34-37.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Chandrasekharan NV, Dai H, Roos KL, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U. S. A. 2002; 99: 13926-13931. Go to original source... Go to PubMed...
    2. Smith HS. Potential analgesic mechanisms of acetaminophen. Pain Physician 2009; 12: 269-280. Go to original source... Go to PubMed...
    3. Ibanez L, Vidal X, Ballarin E, Laporte JR. Agranulocytosis associated with dipyrone (metamizol). Eur J Clin Pharmacol 2005; 60: 821-829. Go to original source... Go to PubMed...
    4. Hedenmalm K, Spigset O. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol 2002; 58: 265-274. Go to original source... Go to PubMed...
    5. Lal A, Gomber S, Talukdar B. Antipyretic effects of nimesulide, paracetamol and ibuprofen-paracetamol. Indian J Pediatr 2000; 67: 865-870. Go to original source... Go to PubMed...
    6. Polidori G, Titti G, Pieragostini P, Comito A, Scaricabarozzi I. A comparison of nimesulide and paracetamol in the treatment of fever due to inflammatory diseases of the upper respiratory tract in children. Drugs 1993; 46(Suppl. 1): 231-233. Go to original source... Go to PubMed...
    7. Dicpinigaitis PV, Gayle YE. Effect of guaifenesin on cough reflex sensitivity. Chest 2003; 124(6): 2178-2181. Go to original source... Go to PubMed...
    8. Slíva J, Doležal T, Sýkora D, Vosmanská M, Kršiak M. Guaifenesin enhances the analgesic potency of ibuprofen, nimesulide and celecoxib in mice. Neuro Endocrinol Lett 2009; 30(3): 153-157. Go to PubMed...
    9. Demirbas S, Reyderman L, Stavchansky S. Bioavailability of dextromthorphan (as dextrorphan) from sustained releaseformulations in the presence of guaifenesin in human volunteers. Biopharm Drug Dispos 1998; 19(8): 541-545. Go to original source... Go to PubMed...
    10. Birt DF, Widrlechner MP, Lalone CA, et al. Echinacea in infection. Am J Clin Nutr 2008; 87: 488-492. Go to original source... Go to PubMed...
    11. Douglas RM, Hemila H, Chalker E, Treacy B. Vitamin C for preventing and treating the common cold. Cochrane Database SystRev 2007; CD000980. Go to original source...
    12. Beasley R, Clayton T, Crane J, et al. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: analysis from Phase Three of the ISAAC programme. Lancet 2008; 372: 1039-1048. Go to original source... Go to PubMed...
    13. Prymula R, Siegrist CA, Chlibek R, et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. Lancet 2009; 374: 1339-1350. Go to original source... Go to PubMed...

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.